136 related articles for article (PubMed ID: 38244700)
1. Disease diagnosis and severity classification in pulmonary fibrosis using carbonyl volatile organic compounds in exhaled breath.
Taylor MJ; Chitwood CP; Xie Z; Miller HA; van Berkel VH; Fu XA; Frieboes HB; Suliman SA
Respir Med; 2024 Feb; 222():107534. PubMed ID: 38244700
[TBL] [Abstract][Full Text] [Related]
2. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
[TBL] [Abstract][Full Text] [Related]
3. The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study.
Plantier L; Smolinska A; Fijten R; Flamant M; Dallinga J; Mercadier JJ; Pachen D; d'Ortho MP; van Schooten FJ; Crestani B; Boots AW
Respir Res; 2022 Jan; 23(1):12. PubMed ID: 35057817
[TBL] [Abstract][Full Text] [Related]
4. Identification of Idiopathic Pulmonary Fibrosis and Prediction of Disease Severity via Machine Learning Analysis of Comprehensive Metabolic Panel and Complete Blood Count Data.
Mueller AN; Miller HA; Taylor MJ; Suliman SA; Frieboes HB
Lung; 2024 Apr; 202(2):139-150. PubMed ID: 38376581
[TBL] [Abstract][Full Text] [Related]
5. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
[TBL] [Abstract][Full Text] [Related]
6. Breath carbonyl compounds as biomarkers of lung cancer.
Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
[TBL] [Abstract][Full Text] [Related]
8. Analysis of a Broad Range of Carbonyl Metabolites in Exhaled Breath by UHPLC-MS.
Xie Z; Morris JD; Mattingly SJ; Sutaria SR; Huang J; Nantz MH; Fu XA
Anal Chem; 2023 Mar; 95(9):4344-4352. PubMed ID: 36815760
[TBL] [Abstract][Full Text] [Related]
9. Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study.
Woollam M; Siegel AP; Grocki P; Saunders JL; Sanders DB; Agarwal M; Davis MD
J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35120338
[TBL] [Abstract][Full Text] [Related]
10. Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?
Guilleminault L; Saint-Hilaire A; Favelle O; Caille A; Boissinot E; Henriet AC; Diot P; Marchand-Adam S
Respir Med; 2013 Nov; 107(11):1789-96. PubMed ID: 24011803
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive detection of lung cancer using exhaled breath.
Fu XA; Li M; Knipp RJ; Nantz MH; Bousamra M
Cancer Med; 2014 Feb; 3(1):174-81. PubMed ID: 24402867
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Ability of Electronic Nose Technology to Recognize Interstitial Lung Diseases (ILD) by Non-Invasive Breath Screening of Exhaled Volatile Compounds (VOC): A Pilot Study from the European IPF Registry (eurIPFreg) and Biobank.
Krauss E; Haberer J; Maurer O; Barreto G; Drakopanagiotakis F; Degen M; Seeger W; Guenther A
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31623141
[TBL] [Abstract][Full Text] [Related]
13. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
Feng H; Zhao Y; Li Z; Kang J
Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
[TBL] [Abstract][Full Text] [Related]
14. Plasma LTBP2 as a potential biomarker in differential diagnosis of connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis: a pilot study.
Zou M; Hu X; Song W; Gao H; Wu C; Zheng W; Cheng Z
Clin Exp Med; 2023 Dec; 23(8):4809-4816. PubMed ID: 37864077
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease.
Bousamra M; Schumer E; Li M; Knipp RJ; Nantz MH; van Berkel V; Fu XA
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1074-80; discussion 1080-1. PubMed ID: 25129599
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
17. Changes in lung epithelial cell volatile metabolite profile induced by pro-fibrotic stimulation with TGF-
Hayton C; Ahmed W; Cunningham P; Piper-Hanley K; Pearmain L; Chaudhuri N; Leonard C; Blaikley JF; Fowler SJ
J Breath Res; 2023 Sep; 17(4):. PubMed ID: 37619557
[TBL] [Abstract][Full Text] [Related]
18. Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function.
Ding F; Yang L; Wang Y; Wang J; Ma Y; Jin J
BMC Pulm Med; 2023 Feb; 23(1):68. PubMed ID: 36800954
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease.
Cameli P; Bargagli E; Bergantini L; Refini RM; Pieroni M; Sestini P; Rottoli P
J Breath Res; 2019 Mar; 13(2):026008. PubMed ID: 30690441
[TBL] [Abstract][Full Text] [Related]
20. Relationship between lung function and exhaled volatile organic compounds in healthy infants.
Sola-Martínez RA; Sanchez-Solis M; Lozano-Terol G; Gallego-Jara J; García-Marcos L; Cánovas Díaz M; de Diego Puente T;
Pediatr Pulmonol; 2022 May; 57(5):1282-1292. PubMed ID: 35092361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]